Home Teva, Active Biotech halt higher doses of oral MS drug in trials
 

Keywords :   


Teva, Active Biotech halt higher doses of oral MS drug in trials

2016-01-04 16:59:51| Biotech - Topix.net

Teva Pharmaceutical Industries and Active Biotech will discontinue higher doses of their oral drug in development for multiple sclerosis in two trials, citing the occurrence of non-fatal cardiovascular events in eight patients. Both trials of laquinimod will continue with the lower dose of 0.6 mg daily where there were no issues.

Tags: active higher drug oral

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
23.11 #249
23.11muta5
23.1120
23.11BabolaT VS BUG4300 24ss
23.11
23.11 TYO26cm
23.112
23.11CW-X 2.0
More »